CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells

Baylin, 2000, DNA hypermethylation in tumorigenesis: epigenetics joins genetics, Trends Genet., 16, 168, 10.1016/S0168-9525(99)01971-X Benda, 1971, Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture, J. Neurosurg., 34, 310, 10.3171/jns.1971.34.3.0310 Boismenu, 1996, A role for CD81 in early T cell development, Science, 271, 198, 10.1126/science.271.5246.198 Boucheix, 2001, Tetraspanins, Cell. Mol. Life Sci., 58, 1189, 10.1007/PL00000933 Cacoub, 2003, Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection, J. Viral Hepatitis, 10, 10, 10.1046/j.1365-2893.2003.00380.x Costello, 2003, DNA methylation in brain development and gliomagenesis, Front. Biosci., 8, s175, 10.2741/1027 Drucker, 2006, Promoter hypermethylation of tetraspanin members contributes to their silencing in myeloma cell lines, Carcinogenesis, 27, 197, 10.1093/carcin/bgi209 Esteller, 2002, CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future, Oncogene, 21, 5427, 10.1038/sj.onc.1205600 Esteller, 1999, hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis, Am. J. Pathol., 155, 1767, 10.1016/S0002-9440(10)65492-2 Esteller, 2000, Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents, N. Engl. J. Med., 343, 1350, 10.1056/NEJM200011093431901 Esteller, 2000, Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors, J. Natl. Cancer Inst., 92, 564, 10.1093/jnci/92.7.564 Esteller, 2002, Cancer epigenetics and methylation, Science, 297, 1807, 10.1126/science.297.5588.1807d Eyupoglu, 2005, Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo, J. Neurochem., 93, 992, 10.1111/j.1471-4159.2005.03098.x Finnin, 1999, Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors, Nature, 401, 188, 10.1038/43710 Fleisher, 1999, Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability, Cancer Res., 59, 1090 Fotakis, 2006, In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride, Toxicol. Lett., 160, 171, 10.1016/j.toxlet.2005.07.001 Geisert, 1996, Astrocyte growth, reactivity, and the target of the antiproliferative antibody, TAPA, J. Neurosci., 16, 5478, 10.1523/JNEUROSCI.16-17-05478.1996 Geisert, 2002, Retinal pigment epithelium of the rat express CD81, the target of the anti-proliferative antibody (TAPA), Invest Ophthalmol. Visual Sci., 43, 274 Geisert, 2002, Increased brain size and glial cell number in CD81-null mice, J. Comp. Neurol., 453, 22, 10.1002/cne.10364 Grant, 2001, A tale of histone modifications, Genome Biol., 2, 3.1, 10.1186/gb-2001-2-4-reviews0003 Hemler, 2003, Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain, Annu. Rev. Cell Dev. Biol., 19, 397, 10.1146/annurev.cellbio.19.111301.153609 Herman, 1995, Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers, Cancer Res., 55, 4525 Herman, 1996, Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B, Cancer Res., 56, 722 Herman, 1997, Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies, Cancer Res., 57, 837 Herold, 2002, The histone–deacetylase inhibitor trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells, J. Hepatol., 36, 233, 10.1016/S0168-8278(01)00257-4 Hoshikawa, 1994, Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines, Exp. Cell Res., 214, 189, 10.1006/excr.1994.1248 Inoue, 2001, The CD81 expression in liver in hepatocellular carcinoma, Int. J. Mol. Med., 7, 67 Ito, 2001, Inhibitory effects of sodium butyrate on proliferation and invasiveness of human glioma cells, Neurosurgery, 49, 430 Jones, 2001, Sensitive determination of cell number using the CyQUANT cell proliferation assay, J. Immunol. Methods, 254, 85, 10.1016/S0022-1759(01)00404-5 Kelic, 2001, CD81 regulates neuron-induced astrocyte cell-cycle exit, Mol. Cell. Neurosci., 17, 551, 10.1006/mcne.2000.0955 Kim, 1999, Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase, Ann. N. Y. Acad. Sci., 886, 200, 10.1111/j.1749-6632.1999.tb09416.x Korzeniewski, 1983, An enzyme-release assay for natural cytotoxicity, J. Immunol. Methods, 64, 313, 10.1016/0022-1759(83)90438-6 Kristeleit, 2004, Histone modification enzymes: novel targets for cancer drugs, Expert Opin. Emerg. Drugs, 9, 135, 10.1517/14728214.9.1.135 Lashford, 1997, Possibilities of gene therapies for cancer, Ann. Med., 29, 1, 10.3109/07853899708998737 Levitz, 1985, A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT, J. Infect. Dis., 152, 938, 10.1093/infdis/152.5.938 Lobner, 2000, Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?, J. Neurosci. Methods, 96, 147, 10.1016/S0165-0270(99)00193-4 Lu, 2004, Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors, J. Med. Chem., 47, 467, 10.1021/jm0303655 Marks, 2000, Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells, J. Natl. Cancer Inst., 92, 1210, 10.1093/jnci/92.15.1210 Marks, 2001, Histone deacetylases and cancer: causes and therapies, Nat. Rev., Cancer, 1, 194, 10.1038/35106079 Marks, 2001, Histone deacetylase inhibitors as new cancer drugs, Curr. Opin. Oncol., 13, 477, 10.1097/00001622-200111000-00010 Marks, 2001, Inhibitors of histone deacetylase are potentially effective anticancer agents, Clin. Cancer Res., 7, 759 Miyazaki, 1997, Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81, EMBO J., 16, 4217, 10.1093/emboj/16.14.4217 Morgan, 1998, Tetrazolium (MTT) assay for cellular viability and activity, Methods Mol. Biol., 79, 179 Munster, 2001, The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells, Cancer Res., 61, 8492 Narayan, 2003, Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome, Mol. Cancer, 2, 24, 10.1186/1476-4598-2-24 Oren, 1990, TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins, Mol. Cell. Biol., 10, 4007 Peixoto, 2006, Histone–deacetylases inhibitors: from TSA to SAHA, Bull. Cancer, 93, 27 Qiu, 1999, Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate, Br. J. Cancer, 80, 1252, 10.1038/sj.bjc.6690493 Sakajiri, 2005, Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines, Exp. Hematol., 33, 53, 10.1016/j.exphem.2004.09.008 Sawa, 2002, Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells, Brain Tumor Pathol., 19, 77, 10.1007/BF02478931 Sawa, 2004, Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo, Acta Neuropathol. (Berl.), 107, 523, 10.1007/s00401-004-0841-3 Schmidek, 1971, Morphological studies of rat brain tumors induced by N-nitrosomethylurea, J. Neurosurg., 34, 335, 10.3171/jns.1971.34.3.0335 Sibenaller, 2005, Genetic characterization of commonly used glioma cell lines in the rat animal model system, Neurosurg. Focus, 19, E1, 10.3171/foc.2005.19.4.2 Song, 2004, Increased density of retinal pigment epithelium in cd81−/− mice, J. Cell. Biochem., 92, 1160, 10.1002/jcb.20145 Sriwilaijaroen, 2004, Cyquant cell proliferation assay as a fluorescence-based method for in vitro screening of antimalarial activity, Southeast Asian J. Trop. Med. Public Health, 35, 840 Stipp, 2003, Functional domains in tetraspanin proteins, Trends Biochem. Sci., 28, 106, 10.1016/S0968-0004(02)00014-2 Su, 2000, A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library, Cancer Res., 60, 3137 Sullivan, 1998, Expression of rat target of the antiproliferative antibody (TAPA) in the developing brain, J. Comp. Neurol., 396, 366, 10.1002/(SICI)1096-9861(19980706)396:3<366::AID-CNE7>3.0.CO;2-0 Suzuki, 2000, Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines, Int. J. Cancer, 88, 992, 10.1002/1097-0215(20001215)88:6<992::AID-IJC24>3.0.CO;2-9 Takahashi, 1990, TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen, J. Immunol., 145, 2207, 10.4049/jimmunol.145.7.2207 Toledo, 2004, Cell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13, J. Biol. Chem., 279, 34655, 10.1074/jbc.M403857200 Vidali, 1978, Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences, Proc. Natl. Acad. Sci. U. S. A., 75, 2239, 10.1073/pnas.75.5.2239 Wang, 1993, A new microcellular cytotoxicity test based on calcein AM release, Hum. Immunol., 37, 264, 10.1016/0198-8859(93)90510-8 Weng, 2003, Hepatitis C virus (HCV) and lymphomagenesis, Leuk. Lymphoma, 44, 1113, 10.1080/1042819031000076972 Yamashita, 2003, Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells, Int. J. Cancer, 103, 572, 10.1002/ijc.10699 Yokomine, 2005, Structural and functional analysis of a 0.5-Mb chicken region orthologous to the imprinted mammalian Ascl2/Mash2-Igf2-H19 region, Genome Res., 15, 154, 10.1101/gr.2609605 Yoshida, 1990, Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A, J. Biol. Chem., 265, 17174, 10.1016/S0021-9258(17)44885-X